More Clever Culture Systems Limited news
Clever Culture Systems LimitedASX: CC5

VRE Analysis Module - Clinical Study Commenced

Mar 19, 2020 at 12:14 AM EDT · Issued by Clever Culture Systems Limited

Filed with ASX · Mar 19, 2020 at 12:14 AM EDT

On 6ix: 6ix.com/news/vre-analysis-module-clinical-study-commenced

Clever Culture Systems Limited has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Clever Culture Systems Limited on 6ix

Story so far

  • MRSA Analysis Module CE Mark RegistrationSep 25, 2019
  • First U.S. Clinical Data with APAS Presented at ASM MicrobeJun 24, 2019
  • MRSA Analysis Module - Clinical Study CommencedApr 2, 2019

Earlier from Clever Culture Systems

  • Johns Hopkins Hosp to Present Study Data APAS IndependenceMar 11, 2020
  • LBT Receives $1.1 Million R&D Tax IncentiveJan 21, 2020
  • Presentation at Biotech Showcase Investor ConferenceJan 13, 2020
  • CEO Presentation - AGM 2019Nov 27, 2019
  • Chairmans Address to ShareholdersNov 27, 2019

Later from Clever Culture Systems

  • US FDA 510(k) Submission for MRSA Analysis ModuleMar 29, 2020
  • Presentation at NWR Virtual Small Cap ConferenceApr 29, 2020
  • South Australian Government Agree to Extend Loan FacilityMay 7, 2020
  • $1.5M Draw Down on South Australian Government LoanMay 25, 2020
  • Update on MRSA Analysis Module US FDA SubmissionJun 3, 2020
All Clever Culture Systems news releases↗

Follow Clever Culture Systems into a list and get an email when it puts out news.

Follow Clever Culture Systems
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer